Ferguson James J. III 4
4 · Matinas BioPharma Holdings, Inc. · Filed Jan 4, 2021
Insider Transaction Report
Form 4
Ferguson James J. III
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2021-01-01+575,000→ 575,000 totalExercise: $1.36Exp: 2030-12-31→ Common Stock (575,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2022 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2022.